title: Clinical significance of keratinocyte growth factor and K-sam gene expression in gastric cancer.
abstract: Although gastric cancer is increasingly being detected at an early stage of development, diffuse growth‑type malignant tumors, such as scirrhous gastric cancer, are usually at an advanced stage at the time of diagnosis, resulting in poor treatment outcomes. The aim of this study was to determine whether the K-sam gene and keratinocyte growth factor (KGF) expression may be used to identify malignant tumors with a poor prognosis. K-sam and KGF expression was retrospectively evaluated in samples from 86 patients with early and advanced gastric cancer according to type, by examining serum levels and using immunohistochemical staining. The associations with clinicopathological characteristics and survival were also examined. The mean serum KGF levels were 11.191±3.808 pg/ml in early stage and 10.715±3.4991 pg/ml in advanced gastric cancer patients. KGF levels were significantly higher in types 4 and 5 (14.498±3.812 pg/ml, n=6) compared with types 1, 2 and 3 (10.747±3.571 pg/ml, n=80; P=0.028). Stage classification was identified as the only significant factor which determined overall survival. Patients with KGF-positive tumors had significantly higher serum KGF levels compared with those who had KGF-negative tumors. Patients with K-sam‑positive tumors had significantly higher KGF levels compared with those who had K-sam-negative tumors. Pathological KGF expression was not significantly correlated with the degree of differentiation; however, there was a positive correlation between high K-sam expression in scirrhous gastric tumors and serum KGF levels. The present study revealed that high serum KGF levels are a risk factor for diffuse infiltrative gastric cancer and may provide a simple method of identifying patients with a poor prognosis among previously diagnosed preoperative gastric cancer patients.
authors.affiliation: Department of Surgery II, Tokyo Women's Medical University, Shinjuku-ku, Tokyo 162-8666, Japan.
authors.forename: Hideki
authors.initials: H
authors.lastname: Tani
authors.forename: Noboru
authors.initials: N
authors.lastname: Saito
authors.forename: Makio
authors.initials: M
authors.lastname: Kobayashi
authors.forename: Shingo
authors.initials: S
authors.lastname: Kameoka
mesh_terms: D005260:Female; D051523:Fibroblast Growth Factor 7 / Q000097:blood / Q000235:genetics*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D053208:Kaplan-Meier Estimate; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D051497:Receptor, Fibroblast Growth Factor, Type 2 / Q000235:genetics* / Q000378:metabolism; D013274:Stomach Neoplasms / Q000097:blood / Q000235:genetics* / Q000473:pathology*
chemical_list: C496453:FGF7 protein, human; D051523:Fibroblast Growth Factor 7; C496353:FGFR2 protein, human; D051497:Receptor, Fibroblast Growth Factor, Type 2
references.citation: Cancer Res. 2003 Dec 15;63(24):8848-52
references.pmid: 14695201
references.citation: Mol Med Rep. 2008 Jan-Feb;1(1):77-81
references.pmid: 21479381
references.citation: Baillieres Clin Gastroenterol. 1996 Mar;10(1):97-112
references.pmid: 8732303
references.citation: Cancer Res. 1994 Jan 15;54(2):518-22
references.pmid: 8275490
references.citation: Hepatogastroenterology. 2007 Jun;54(76):1049-52
references.pmid: 17629036
references.citation: Jpn J Cancer Res. 1994 Sep;85(9):883-6
references.pmid: 7961114
references.citation: Gastroenterology. 2006 Nov;131(5):1530-41
references.pmid: 17101326
references.citation: Gastric Cancer. 1998 Dec;1(1):10-24
references.pmid: 11957040
references.citation: Cancer Res. 2008 Apr 1;68(7):2340-8
references.pmid: 18381441
references.citation: Clin Cancer Res. 1996 Aug;2(8):1373-81
references.pmid: 9816310
references.citation: Jpn J Cancer Res. 1986 Sep;77(9):849-53
references.pmid: 3095279
references.citation: Br J Cancer. 1996 Oct;74(7):1096-103
references.pmid: 8855981
references.citation: Int Surg. 2009 Apr-Jun;94(2):182-8
references.pmid: 20108624
references.citation: Int J Oncol. 2006 Jul;29(1):163-8
references.pmid: 16773196
references.citation: Mol Cell Biol. 1995 Jul;15(7):3664-71
references.pmid: 7791773
references.citation: Cytokine Growth Factor Rev. 2005 Apr;16(2):159-78
references.pmid: 15863032
references.citation: Jpn J Cancer Res. 1990 Aug;81(8):707-10
references.pmid: 2168864
references.citation: Oncol Rep. 2009 Apr;21(4):875-80
references.pmid: 19287982
references.citation: Cancer Res. 1994 Jun 15;54(12):3237-41
references.pmid: 8205545
references.citation: J Natl Cancer Inst. 2006 Jun 21;98(12):812-24
references.pmid: 16788155